KI
GILD icon

Keystone Investors’s Gilead Sciences GILD Stock Holding History

Keystone Investors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$25.5M Buy
+207,554
New +$25.2M 2.29% 12

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Keystone Investors's GILD Position: Q4 2025 in Review

Keystone Investors opened a new position in Gilead Sciences (GILD) in Q4 2025: 207,554 shares worth $25.5M. The stake represents 2.29% of the portfolio and ranks #12 among its holdings.

2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Keystone Investors held 207,554 shares of Gilead Sciences worth $25.5M as of Q4 2025.
  • Gilead Sciences was a new Keystone Investors position in Q4 2025.
  • Gilead Sciences made up 2.29% of Keystone Investors's portfolio in Q4 2025, its #12 holding.
  • 2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Keystone Investors's 13F filing for Q4 2025, filed 13 Feb 2026.